TY  - GEN
AU  - Sukul,Devraj
AU  - Seth,Milan
AU  - Schreiber,Theodore
AU  - Hanzel,George
AU  - Khandelwal,Akshay
AU  - Cannon,Louis A
AU  - Lalonde,Thomas A
AU  - Gurm,Hitinder S
TI  - The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
SN  - 1540-8183
PY  - 2018///0322
KW  - Abciximab
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Blue Cross Blue Shield Insurance Plans
KW  - Contraindications, Drug
KW  - Eptifibatide
KW  - Female
KW  - Heparin
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Male
KW  - Michigan
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - therapy
KW  - Peptides
KW  - Percutaneous Coronary Intervention
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Postoperative Complications
KW  - epidemiology
KW  - Renal Dialysis
KW  - Retrospective Studies
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1111/joic.12388
ER  -